Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  401 results for ""SEVERITY of illness index""

Your Filters

Publisher : wiley-blackwell Geographic : japan Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20-week interim analysis of a postmarketing surveillance study.

  • Authors : Tada Y; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.; Sugiura Y

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage ; Product Surveillance, Postmarketing*

  • Source: The Journal of dermatology [J Dermatol] 2024 Jun; Vol. 51 (6), pp. 779-790. Date of Electronic Publication: 2024 May 15.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Real-world effectiveness and safety of abrocitinib in 12 Japanese patients with atopic dermatitis and transcriptome analysis with peripheral blood.

  • Authors : Uchiyama A; Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.; Kosaka K

Subjects: Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/blood ; Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/diagnosis ; Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/drug therapy

  • Source: The Journal of dermatology [J Dermatol] 2024 Jun; Vol. 51 (6), pp. 849-853. Date of Electronic Publication: 2024 Mar 03.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Validation of the Index for Facial Angiofibromas: Data analysis from a randomized controlled trial of sirolimus gel treatment in patients with tuberous sclerosis complex.

  • Authors : Hamada I; Research & Development Division, Nobelpharma Co., Ltd, Tokyo, Japan.; Yukutake Y

Subjects: Tuberous Sclerosis*/Tuberous Sclerosis*/Tuberous Sclerosis*/drug therapy ; Tuberous Sclerosis*/Tuberous Sclerosis*/Tuberous Sclerosis*/diagnosis ; Tuberous Sclerosis*/Tuberous Sclerosis*/Tuberous Sclerosis*/complications

  • Source: The Journal of dermatology [J Dermatol] 2024 Jun; Vol. 51 (6), pp. 752-758. Date of Electronic Publication: 2024 Apr 15.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Real-world effectiveness and safety of bimekizumab in Japanese patients with psoriasis: A single-center retrospective study.

  • Authors : Hagino T; Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.; Saeki H

Subjects: Psoriasis*/Psoriasis*/Psoriasis*/drug therapy ; Psoriasis*/Psoriasis*/Psoriasis*/immunology ; Psoriasis*/Psoriasis*/Psoriasis*/diagnosis

  • Source: The Journal of dermatology [J Dermatol] 2024 May; Vol. 51 (5), pp. 649-658. Date of Electronic Publication: 2024 Mar 14.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Cost-effectiveness analysis of abrocitinib compared with standard of care in adult moderate-to-severe atopic dermatitis in Japan.

  • Authors : Tanaka A; Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.; Yuasa A

Subjects: Cost-Benefit Analysis* ; Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/drug therapy ; Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/economics

  • Source: The Journal of dermatology [J Dermatol] 2024 Jun; Vol. 51 (6), pp. 759-771. Date of Electronic Publication: 2024 Apr 22.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Reliability, validity, and sensitivity of the Japanese version of the University of California Los Angeles scleroderma clinical trial consortium gastrointestinal tract instrument: Application to efficacy assessment of intravenous immunoglobulin administration.

  • Authors : Matsuda KM; Department of Dermatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Sugimoto E

Subjects: Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/administration & dosage ; Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/therapeutic use ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/drug therapy

  • Source: The Journal of dermatology [J Dermatol] 2024 Jun; Vol. 51 (6), pp. 741-751. Date of Electronic Publication: 2024 Apr 01.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Epidemiology of severe childhood asthma in Japan: A nationwide descriptive study.

  • Authors : Kimura Y; Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.; Clinical Research Center, National Hospital Organization Tokyo Hospital, Tokyo, Japan.

Subjects: Asthma*/Asthma*/Asthma*/epidemiology; Humans ; Japan/Japan/Japan/epidemiology

  • Source: Allergy [Allergy] 2024 Jun; Vol. 79 (6), pp. 1598-1602. Date of Electronic Publication: 2024 Jan 07.Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of filgotinib for ulcerative colitis: A real-world multicenter retrospective study in Japan.

  • Authors : Akiyama S; Department of Gastroenterology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.; Yokoyama K

Subjects: Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/drug therapy; Humans ; Male

  • Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Jun; Vol. 59 (11), pp. 1413-1424. Date of Electronic Publication: 2024 Mar 17.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Anifrolumab for systemic lupus erythematosus: A clinical study of Japanese patients in Kanazawa University Hospital.

  • Authors : Fushida N; Department of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.; Horii M

Subjects: Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/drug therapy ; Antibodies, Monoclonal, Humanized*; Female

  • Source: The Journal of dermatology [J Dermatol] 2024 Apr; Vol. 51 (4), pp. 607-611. Date of Electronic Publication: 2023 Nov 06.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial.

  • Authors : Imafuku S; Department of Dermatology, Fukuoka University Faculty of Medicine, Fukuoka, Japan.; Okubo Y

Subjects: Psoriasis*/Psoriasis*/Psoriasis*/drug therapy ; Psoriasis*/Psoriasis*/Psoriasis*/chemically induced ; Exanthema*/Exanthema*/Exanthema*/drug therapy

  • Source: The Journal of dermatology [J Dermatol] 2024 Mar; Vol. 51 (3), pp. 365-379. Date of Electronic Publication: 2024 Jan 24.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  401 results for ""SEVERITY of illness index""